Impact of acetylation on tumor metabolism

Molecular and Cellular Oncology

Volumn 1, Issue 3, 2014, Pages

  Zhao, Di ^a,b   Li, Fu Long ^a,b   Cheng, Zhou Li ^a,b   Lei, Qun Ying ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

acetylation; metabolic enzyme; oncogene; tumor metabolism; tumor suppressor

Indexed keywords

EID: 85029407726     PISSN: None     EISSN: 23723556     Source Type: Journal    
DOI: 10.4161/23723548.2014.963452     Document Type: Article

References (109)

1. Allis CD, Berger SL, Cote J, Dent S, Jenuwien T, Kouzarides T, Pillus L, Reinberg D, Shi Y, Shiekhattar R, et al. New nomenclature for chromatin-modifying enzymes. Cell 2007; 131:633-6; PMID:18022353; http://dx.doi.org/10.1016/j.cell.2007.10.039
2. Kleff S, Andrulis ED, Anderson CW, Sternglanz R. Identification of a gene encoding a yeast histone H4 acetyltransferase. J Biol Chem 1995; 270:24674-7; PMID:7559580; http://dx.doi.org/10.1074/jbc.270.42.24674
3. Goodman RH, Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Dev 2000; 14:1553-77; PMID:10887150
4. Yao TP, Oh SP, Fuchs M, Zhou ND, Ch'ng LE, Newsome D, Bronson RT, Li E, Livingston DM, Eckner R. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 1998; 93:361-72; PMID:9590171; http://dx.doi.org/10.1016/S0092-8674(00)81165-4
5. Ito A, Kawaguchi Y, Lai CH, Kovacs JJ, Higashimoto Y, Appella E, Yao TP. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J 2002; 21:6236-45; PMID:12426395; http://dx.doi.org/10.1093/emboj/cdf616
6. Akimova T, Beier UH, Liu Y, Wang L, Hancock WW. Histone/protein deacetylases and T-cell immune responses. Blood 2012; 119:2443-51; PMID:22246031; http://dx.doi.org/10.1182/blood-2011-10-292003
7. Cook C, Gendron TF, Scheffel K, Carlomagno Y, Dunmore J, DeTure M, Petrucelli L. Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation. Hum Mol Genet 2012; 21:2936-45; PMID:22492994; http://dx.doi.org/10.1093/hmg/dds125
8. Lee YS, Lim KH, Guo X, Kawaguchi Y, Gao Y, Barrientos T, Ordentlich P, Wang XF, Counter CM, Yao TP. The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis. Cancer Res 2008; 68:7561-9; PMID:18794144; http://dx.doi.org/10.1158/0008-5472.CAN-08-0188
9. Preyat N, Leo O. Sirtuin deacylases: a molecular link between metabolism and immunity. J Leukoc Biol 2013; 93:669-80; PMID:23325925; http://dx.doi.org/10.1189/jlb.1112557
10. Du J, Zhou Y, Su X, Yu JJ, Khan S, Jiang H, Kim J, Woo J, Kim JH, Choi BH, et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 2011; 334:806-9; PMID:22076378; http://dx.doi.org/10.1126/science.1207861
11. Semenza GL. Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin Cancer Biol 2009; 19:12-6; PMID:19114105; http://dx.doi.org/10.1016/j.semcancer.2008.11.009
12. Brand K. Glutamine and glucose metabolism during thymocyte proliferation. Pathways of glutamine and glutamate metabolism. Biochem J 1985; 228:353-61; PMID:2861809
13. Hedeskov CJ. Early effects of phytohaemagglutinin on glucose metabolism of normal human lymphocytes. Biochem J 1968; 110:373-80; PMID:5726214
14. Guppy M, Greiner E, Brand K. The role of the Crabtree effect and an endogenous fuel in the energy metabolism of resting and proliferating thymocytes. Eur J Biochem 1993; 212:95-9; PMID:8444168; http://dx.doi.org/10.1111/j.1432-1033.1993.tb17637.x
15. Locasale JW. Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat Rev Cancer 2013; 13:572-83; PMID:23822983; http://dx.doi.org/10.1038/nrc3557
16. Owen OE, Kalhan SC, Hanson RW. The key role of anaplerosis and cataplerosis for citric acid cycle function. J Biol Chem 2002; 277:30409-12; PMID:12087111; http://dx.doi.org/10.1074/jbc.R200006200
17. Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci 2010; 35:427-33; PMID:20570523; http://dx.doi.org/10.1016/j.tibs.2010.05.003
18. Taylor CT, Pouyssegur J. Oxygen, hypoxia, and stress. Ann N Y Acad Sci 2007; 1113:87-94; PMID:17483207; http://dx.doi.org/10.1196/annals.1391.004
19. Pouyssegur J, Dayan F, Mazure NM. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 2006; 441:437-43; PMID:16724055; http://dx.doi.org/10.1038/nature04871
20. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006; 3:177-85; PMID:16517405; http://dx.doi.org/10.1016/j.cmet.2006.02.002
21. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 2006; 3:187-97; PMID:16517406; http://dx.doi.org/10.1016/j.cmet.2006.01.012
22. Wang HQ, Altomare DA, Skele KL, Poulikakos PI, Kuhajda FP, Di Cristofano A, Testa JR. Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells. Oncogene 2005; 24:3574-82; PMID:15806173; http://dx.doi.org/10.1038/sj.onc.1208463
23. Shaw RJ, Cantley LC. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 2006; 441:424-30; PMID:16724053; http://dx.doi.org/10.1038/nature04869
24. Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim SH, Ito S, Yang C, Xiao MT, Liu LX, et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell 2011; 19:17-30; PMID:21251613; http://dx.doi.org/10.1016/j.ccr.2010.12.014
25. Xiao M, Yang H, Xu W, Ma S, Lin H, Zhu H, Liu L, Liu Y, Yang C, Xu Y, et al. Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev 2012; 26:1326-38; PMID:22677546; http://dx.doi.org/10.1101/gad.191056.112
26. Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H, Schmidt K, Willson JK, Markowitz S, Zhou S, et al. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science 2009; 325:1555-9; PMID:19661383; http://dx.doi.org/10.1126/science.1174229
27. MacKenzie ED, Selak MA, Tennant DA, Payne LJ, Crosby S, Frederiksen CM, Watson DG, Gottlieb E. Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells. Mol Cell Biol 2007; 27:3282-9; PMID:17325041; http://dx.doi.org/10.1128/MCB.01927-06
28. Deberardinis RJ, Lum JJ, Thompson CB. Phosphatidylinositol 3-kinase-dependent modulation of carnitine palmitoyltransferase 1A expression regulates lipid metabolism during hematopoietic cell growth. J Biol Chem 2006; 281:37372-80; PMID:17030509; http://dx.doi.org/10.1074/jbc.M608372200
29. Evans JM, Ogston SA, Emslie-Smith A, Morris AD. Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 2006; 49:930-6; PMID:16525843; http://dx.doi.org/10.1007/s00125-006-0176-9
30. Muller FL, Colla S, Aquilanti E, Manzo VE, Genovese G, Lee J, Eisenson D, Narurkar R, Deng P, Nezi L, et al. Passenger deletions generate therapeutic vulnerabilities in cancer. Nature 2012; 488:337-42; PMID:22895339; http://dx.doi.org/10.1038/nature11331
31. Bonnet S, Archer SL, Allalunis-Turner J, Haromy A, Beaulieu C, Thompson R, Lee CT, Lopaschuk GD, Puttagunta L, Harry G, et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 2007; 11:37-51; PMID:17222789; http://dx.doi.org/10.1016/j.ccr.2006.10.020
32. Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, Royer RE, Vander Jagt DL, Semenza GL, Dang CV. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci U S A 2010; 107:2037-42; PMID:20133848; http://dx.doi.org/10.1073/pnas.0914433107
33. Rohle D, Popovici-Muller J, Palaskas N, Turcan S, Grommes C, Campos C, Tsoi J, Clark O, Oldrini B, Komisopoulou E, et al. An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. Science 2013; 340:626-30; PMID:23558169; http://dx.doi.org/10.1126/science.1236062
34. Glozak MA, Seto E. Histone deacetylases and cancer. Oncogene 2007; 26:5420-32; PMID:17694083; http://dx.doi.org/10.1038/sj.onc.1210610
35. Spiegel S, Milstien S, Grant S. Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy. Oncogene 2012; 31:537-51; PMID:21725353
36. Rius M, Lyko F. Epigenetic cancer therapy: rationales, targets and drugs. Oncogene 2012; 31:4257-65; PMID:22179827; http://dx.doi.org/10.1038/onc.2011.601
37. Riggs MG, Whittaker RG, Neumann JR, Ingram VM. n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells. Nature 1977; 268:462-4; PMID:268489; http://dx.doi.org/10.1038/268462a0
38. Lee JV, Carrer A, Shah S, Snyder NW, Wei S, Venneti S, Worth AJ, Yuan ZF, Lim HW, Liu S, et al. Akt-Dependent Metabolic Reprogramming Regulates Tumor Cell Histone Acetylation. Cell Metabolism 2014; 20:306-19; PMID:24998913; http://dx.doi.org/10.1016/j.cmet.2014.06.00
39. Marino G, Pietrocola F, Eisenberg T, Kong YL, Malik SA, Andryushkova A, Schroeder S, Pendl T, Harger A, Niso-Santano M, et al. Regulation of autophagy by cytosolic acetyl-coenzyme A. Molecular Cell 2014; 53:710-25; PMID:24560926; http://dx.doi.org/10.1016/j.molcel.2014.01.016
40. Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 2009; 324:1076-80; PMID:19461003; http://dx.doi.org/10.1126/science.1164097
41. Sutendra G KA, Dromparis P, Paulin R, Stenson TH, Haromy A, Hashimoto K, Zhang N, Flaim E, Michelakis ED. A nuclear pyruvate dehydrogenase complex is important for the generation of acetyl-CoA and histone acetylation. Cell 2014; 158:84-97; PMID:24995980; http://dx.doi.org/10.1016/j.cell.2014.04.046
42. Xenaki G, Ontikatze T, Rajendran R, Stratford IJ, Dive C, Krstic-Demonacos M, Demonacos C. PCAF is an HIF-1alpha cofactor that regulates p53 transcriptional activity in hypoxia. Oncogene 2008; 27:5785-96; PMID:18574470; http://dx.doi.org/10.1038/onc.2008.192
43. Lim JH, Lee YM, Chun YS, Chen J, Kim JE, Park JW. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol Cell 2010; 38:864-78; PMID:20620956; http://dx.doi.org/10.1016/j.molcel.2010.05.023
44. Wahlstrom T, Henriksson MA. Impact of MYC in regulation of tumor cell metabolism. Biochim Biophys Acta 2014; S1874-9399:00192-8; PMID:25038584
45. Vervoorts J, Luscher-Firzlaff JM, Rottmann S, Lilischkis R, Walsemann G, Dohmann K, Austen M, Luscher B. Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep 2003; 4:484-90; PMID:12776737; http://dx.doi.org/10.1038/sj.embor.embor821
46. Faiola F, Liu X, Lo S, Pan S, Zhang K, Lymar E, Farina A, Martinez E. Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription. Mol Cell Biol 2005; 25:10220-34; PMID:16287840; http://dx.doi.org/10.1128/MCB.25.23.10220-10234.2005
47. Patel JH, Du Y, Ard PG, Phillips C, Carella B, Chen CJ, Rakowski C, Chatterjee C, Lieberman PM, Lane WS, et al. The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60. Mol Cell Biol 2004; 24:10826-34; PMID:15572685; http://dx.doi.org/10.1128/MCB.24.24.10826-10834.2004
48. Yang MH, Nickerson S, Kim ET, Liot C, Laurent G, Spang R, Philips MR, Shan Y, Shaw DE, Bar-Sagi D, et al. Regulation of RAS oncogenicity by acetylation. Proc Natl Acad Sci U S A 2012; 109:10843-8; PMID:22711838; http://dx.doi.org/10.1073/pnas.1201487109
49. Yang MH, Laurent G, Bause AS, Spang R, German N, Haigis MC, Haigis KM. HDAC6 and SIRT2 regulate the acetylation state and oncogenic activity of mutant K-RAS. Mol Cancer Res 2013; 11:1072-7; PMID:23723075; http://dx.doi.org/10.1158/1541-7786.MCR-13-0040-T
50. Ying H, Kimmelman AC, Lyssiotis CA, Hua S, Chu GC, Fletcher-Sananikone E, Locasale JW, Son J, Zhang H, Coloff JL, et al. Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell 2012; 149:656-70; PMID:22541435; http://dx.doi.org/10.1016/j.cell.2012.01.058
51. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E, Vousden KH. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006; 126:107-20; PMID:16839880; http://dx.doi.org/10.1016/j.cell.2006.05.036
52. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, Hwang PM. p53 regulates mitochondrial respiration. Science 2006; 312:1650-3; PMID:16728594; http://dx.doi.org/10.1126/science.1126863
53. Corcoran CA, Huang Y, Sheikh MS. The regulation of energy generating metabolic pathways by p53. Cancer Biol Ther 2006; 5:1610-3; PMID:17204863; http://dx.doi.org/10.4161/cbt.5.12.3617
54. Chao C, Wu Z, Mazur SJ, Borges H, Rossi M, Lin T, Wang JY, Anderson CW, Appella E, Xu Y. Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage. Mol Cell Biol 2006; 26:6859-69; PMID:16943427; http://dx.doi.org/10.1128/MCB.00062-06
55. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005; 436:725-30; PMID:16079851; http://dx.doi.org/10.1038/nature03918
56. Ortega-Molina A SM. PTEN in cancer, metabolism, and aging. Trends Endocrinol Metab 2013; 24:184-9; PMID:23245767; http://dx.doi.org/10.1016/j.tem.2012.11.002
57. Ikenoue T, Inoki K, Zhao B, Guan KL. PTEN acetylation modulates its interaction with PDZ domain. Cancer Res 2008; 68:6908-12; PMID:18757404; http://dx.doi.org/10.1158/0008-5472.CAN-08-1107
58. Song MS, Salmena L, Pandolfi PP. The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 2012; 13:283-96; PMID:22473468
59. Fang M, Shen Z, Huang S, Zhao L, Chen S, Mak TW, Wang X. The ER UDPase ENTPD5 promotes protein N-glycosylation, the Warburg effect, and proliferation in the PTEN pathway. Cell 2010; 143:711-24; PMID:21074248; http://dx.doi.org/10.1016/j.cell.2010.10.010
60. Nicolay BN, Dyson NJ. The multiple connections between pRB and cell metabolism. Curr Opin Cell Biol 2013; 25:735-40; PMID:23916769; http://dx.doi.org/10.1016/j.ceb.2013.07.012
61. Takahashi C, Sasaki N, Kitajima S. Twists in views on RB functions in cellular signaling, metabolism and stem cells. Cancer Sci 2012; 103:1182-8; PMID:22448711; http://dx.doi.org/10.1111/j.1349-7006.2012.02284.x
62. Chan HM, Krstic-Demonacos M, Smith L, Demonacos C, La Thangue NB. Acetylation control of the retinoblastoma tumour-suppressor protein. Nat Cell Biol 2001; 3:667-74; PMID:11433299; http://dx.doi.org/10.1038/35083062
63. Markham D, Munro S, Soloway J, O'Connor DP, La Thangue NB. DNA-damage-responsive acetylation of pRb regulates binding to E2F-1. EMBO Rep 2006; 7:192-8; PMID:16374512; http://dx.doi.org/10.1038/sj.embor.7400591
64. Zhao S, Xu W, Jiang W, Yu W, Lin Y, Zhang T, Yao J, Zhou L, Zeng Y, Li H, et al. Regulation of cellular metabolism by protein lysine acetylation. Science 2010; 327:1000-4; PMID:20167786; http://dx.doi.org/10.1126/science.1179689
65. Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009; 325:834-40; PMID:19608861; http://dx.doi.org/10.1126/science.1175371
66. Kim SC, Sprung R, Chen Y, Xu Y, Ball H, Pei J, Cheng T, Kho Y, Xiao H, Xiao L, et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell 2006; 23:607-18; PMID:16916647; http://dx.doi.org/10.1016/j.molc-el.2006.06.026
67. Lundby A LK, Weinert BT, Bekker-Jensen DB, Secher A, Skovgaard T, Kelstrup CD, Dmytriyev A, Choudhary C, Lundby C, Olsen JV. Proteomic analysis of lysine acetylation sites in rat tissues reveals organ specificity and subcellular patterns. Cell Reports 2012; 2:419-31; PMID:22902405; http://dx.doi.org/10.1016/j.celrep.2012.07.006
68. Xiong Y, Guan KL. Mechanistic insights into the regulation of metabolic enzymes by acetylation. J Cell Biol 2012; 198:155-64; PMID:22826120; http://dx.doi.org/10.1083/jcb.201202056
69. Yu W, Lin Y, Yao J, Huang W, Lei QY, Xiong Y, Zhao SM, Guan KL. Lysine 88 Acetylation Negatively Regulates Ornithine Carbamoyltransferase Activity in Response to Nutrient Signals. J Biol Chem 2009; 284:13669-75; PMID:19318352; http://dx.doi.org/10.1074/jbc.M901921200
70. Jiang WQ, Wang SW, Xiao MT, Lin Y, Zhou LS, Lei QY, Xiong Y, Guan KL, Zhao SM. Acetylation Regulates Gluconeogenesis by Promoting PEPCK1 Degradation via Recruiting the UBR5 Ubiquitin Ligase. Mol Cell 2011; 43:33-44; PMID:21726808; http://dx.doi.org/10.1016/j.molcel.2011.04.028
71. Lv L, Li D, Zhao D, Lin R, Chu Y, Zhang H, Zha Z, Liu Y, Li Z, Xu Y, et al. Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth. Mol Cell 2011; 42:719-30; PMID:21700219; http://dx.doi.org/10.1016/j.molcel.2011.04.025
72. Zhao D, Zou SW, Liu Y, Zhou X, Mo Y, Wang P, Xu YH, Dong B, Xiong Y, Lei QY, et al. Lysine-5 acetylation negatively regulates lactate dehydrogenase A and is decreased in pancreatic cancer. Cancer Cell 2013; 23:464-76; PMID:23523103; http://dx.doi.org/10.1016/j.ccr.2013.02.005
73. Wang Q, Zhang Y, Yang C, Xiong H, Lin Y, Yao J, Li H, Xie L, Zhao W, Yao Y, et al. Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux. Science 2010; 327:1004-7; PMID:20167787; http://dx.doi.org/10.1126/science.1179687
74. Li T, Liu M, Feng X, Wang Z, Das I, Xu Y, Zhou X, Sun Y, Guan KL, Xiong Y, et al. Glyceraldehyde-3-phosphate dehydrogenase is activated by lysine 254 acetylation in response to glucose signal. J Biol Chem 2014; 289:3775-85; PMID:24362262; http://dx.doi.org/10.1074/jbc.M113.531640
75. Hallows WC, Yu W, Denu JM. Regulation of glycolytic enzyme phosphoglycerate mutase-1 by Sirt1 protein-mediated deacetylation. J Biol Chem 2012; 287:3850-8; PMID:22157007; http://dx.doi.org/10.1074/jbc.M111.317404
76. Fan J, Shan C, Kang HB, Elf S, Xie J, Tucker M, Gu TL, Aguiar M, Lonning S, Chen H, et al. Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex. Mol Cell 2014; 53:534-48; PMID:24486017; http://dx.doi.org/10.1016/j.molcel.2013.12.026
77. Someya S, Yu W, Hallows WC, Xu J, Vann JM, Leeuwenburgh C, Tanokura M, Denu JM, Prolla TA. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 2010; 143:802-12; PMID:21094524; http://dx.doi.org/10.1016/j.cell.2010.10.002
78. Cimen H, Han MJ, Yang Y, Tong Q, Koc H, Koc EC. Regulation of succinate dehydrogenase activity by SIRT3 in mammalian mitochondria. Biochemistry 2010; 49:304-11; PMID:20000467; http://dx.doi.org/10.1021/bi901627u
79. McBrayer SK, Yarrington M, Qian J, Feng G, Shanmugam M, Gandhi V, Krett NL, Rosen ST. Integrative gene expression profiling reveals G6PD-mediated resistance to RNA-directed nucleoside analogues in B-cell neoplasms. PLoS One 2012; 7:e41455; PMID:22848499
80. Zhang C, Zhang Z, Zhu Y, Qin S. Glucose-6-phosphate dehydrogenase: a biomarker and potential therapeutic target for cancer. Anticancer Agents Med Chem 2014; 14:280-9; PMID:24066844; http://dx.doi.org/10.2174/18715206113136660337
81. Lin R, Tao R, Gao X, Li T, Zhou X, Guan KL, Xiong Y, Lei QY. Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth. Mol Cell 2013; 51:506-18; PMID:23932781; http://dx.doi.org/10.1016/j.molcel.2013.07.002
82. Yeh CS, Wang JY, Cheng TL, Juan CH, Wu CH, Lin SR. Fatty acid metabolism pathway play an important role in carcinogenesis of human colorectal cancers by Microarray-Bioinformatics analysis. Cancer Lett 2006; 233:297-308; PMID:15885896; http://dx.doi.org/10.1016/j.canlet.2005.03.050
83. Pyne S, Bittman R, Pyne NJ. Sphingosine kinase inhibitors and cancer: seeking the golden sword of Hercules. Cancer Res 2011; 71:6576-82; PMID:21940750; http://dx.doi.org/10.1158/0008-5472.CAN-11-2364
84. Yu H, Shao Y, Gao L, Zhang L, Guo K, Wu C, Hu X, Duan H. Acetylation of sphingosine kinase 1 regulates cell growth and cell-cycle progression. Biochem Biophys Res Commun 2012; 417:1242-7; PMID:22227192; http://dx.doi.org/10.1016/j.bbrc.2011.12.117
85. Schlicker C, Gertz M, Papatheodorou P, Kachholz B, Becker CF, Steegborn C. Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J Mol Biol 2008; 382:790-801; PMID:18680753; http://dx.doi.org/10.1016/j.jmb.2008.07.048
86. Lombard DB, Alt FW, Cheng HL, Bunkenborg J, Streeper RS, Mostoslavsky R, Kim J, Yancopoulos G, Valenzuela D, Murphy A, et al. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol 2007; 27:8807-14; PMID:17923681; http://dx.doi.org/10.1128/MCB.01636-07
87. Haigis MC, Mostoslavsky R, Haigis KM, Fahie K, Christodoulou DC, Murphy AJ, Valenzuela DM, Yancopoulos GD, Karow M, Blander G, et al. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 2006; 126:941-54; PMID:16959573; http://dx.doi.org/10.1016/j.cell.2006.06.057
88. Starai VJ, Celic I, Cole RN, Boeke JD, Escalante-Semerena JC. Sirt2-dependent activation of acetyl-CoA synthetase by deacetylation of active lysine. Science 2002; 298:2390-2; PMID:12493915; http://dx.doi.org/10.1126/science.1077650
89. Hallows WC, Lee S, Denu JM. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc Natl Acad Sci U S A 2006; 103:10230-5; PMID:16790548; http://dx.doi.org/10.1073/pnas.0604392103
90. Schwer B, Bunkenborg J, Verdin RO, Andersen JS, Verdin E. Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc Natl Acad Sci U S A 2006; 103:10224-9; PMID:16788062; http://dx.doi.org/10.1073/pnas.0603968103
91. Yoshimoto M, Waki A, Yonekura Y, Sadato N, Murata T, Omata N, Takahashi N, Welch MJ, Fujibayashi Y. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. Nucl Med Biol 2001; 28:117-22; PMID:11295421; http://dx.doi.org/10.1016/S0969-8051(00)00195-5
92. Qiu X, Brown K, Hirschey MD, Verdin E, Chen D. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 2010; 12:662-7; PMID:21109198; http://dx.doi.org/10.1016/j.cmet.2010.11.015
93. Chen Y, Zhang J, Lin Y, Lei Q, Guan KL, Zhao S, Xiong Y. Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS. EMBO Rep 2011; 12:534-41; PMID:21566644; http://dx.doi.org/10.1038/embor.2011.65
94. Tao R, Coleman MC, Pennington JD, Ozden O, Park SH, Jiang H, Kim HS, Flynn CR, Hill S, Hayes McDonald W, et al. Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol Cell 2010; 40:893-904; PMID:21172655; http://dx.doi.org/10.1016/j.molcel.2010.12.013
95. Luo W, Hu H, Chang R, Zhong J, Knabel M, O'Meally R, Cole RN, Pandey A, Semenza GL. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 2011; 145:732-44; PMID:21620138; http://dx.doi.org/10.1016/j.cell.011.03.054
96. Yang W, Xia Y, Ji H, Zheng Y, Liang J, Huang W, Gao X, Aldape K, Lu Z. Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation. Nature 2011; 480:118-22; PMID:22056988; http://dx.doi.org/10.1038/nature10598
97. Gao X, Wang H, Yang JJ, Liu X, Liu ZR. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol Cell 2012; 45:598-609; PMID:22306293; http://dx.doi.org/10.1016/j.molc-el.2012.01.001
98. Yang W, Xia Y, Hawke D, Li X, Liang J, Xing D, Aldape K, Hunter T, Alfred Yung WK, Lu Z. PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell 2012; 150:685-96; PMID:22901803; http://dx.doi.org/10.1016/j.cell.2012.07.018
99. Lv L, Xu YP, Zhao D, Li FL, Wang W, Sasaki N, Jiang Y, Zhou X, Li TT, Guan KL, et al. Mitogenic and oncogenic stimulation of K433 acetylation promotes PKM2 protein kinase activity and nuclear localization. Mol Cell 2013; 52:340-52; PMID:24120661; http://dx.doi.org/10.1016/j.molcel.2013.09.004
100. Sirover MA. New nuclear functions of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in mammalian cells. J Cell Biochem 2005; 95:45-52; PMID:15770658; http://dx.doi.org/10.1002/jcb.20399
101. Ventura M, Mateo F, Serratosa J, Salaet I, Carujo S, Bachs O, Pujol MJ. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase is regulated by acetylation. Int J Biochem Cell Biol 2010; 42:1672-80; PMID:20601085; http://dx.doi.org/10.1016/j.biocel.2010.06.014
102. Roland BP, Stuchul KA, Larsen SB, Amrich CG, Vandemark AP, Celotto AM, Palladino MJ. Evidence of a triosephosphate isomerase non-catalytic function crucial to behavior and longevity. J Cell Sci 2013; 126:3151-8; PMID:23641070; http://dx.doi.org/10.1242/jcs.124586
103. Chen L, Fischle W, Verdin E, Greene WC. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 2001; 293:1653-7; PMID:11533489; http://dx.doi.org/10.1126/science.1062374
104. Yuan ZL, Guan YJ, Chatterjee D, Chin YE. Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science 2005; 307:269-73; PMID:15653507; http://dx.doi.org/10.1126/science.1105166
105. Kramer OH, Baus D, Knauer SK, Stein S, Jager E, Stauber RH, Grez M, Pfitzner E, Heinzel T. Acetylation of Stat1 modulates NF-kappaB activity. Genes Dev 2006; 20:473-85; PMID:16481475; http://dx.doi.org/10.1101/gad.364306
106. Gay F, Calvo D, Lo MC, Ceron J, Maduro M, Lin R, Shi Y. Acetylation regulates subcellular localization of the Wnt signaling nuclear effector POP-1. Genes Dev 2003; 17:717-22; PMID:12651889; http://dx.doi.org/10.1101/gad.1042403
107. Pate KT, Stringari C, Sprowl-Tanio S, Wang K, TeSlaa T, Hoverter NP, McQuade MM, Garner C, Digman MA, Teitell MA, et al. Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer. EMBO J 2014; 33:1454-73; PMID:24825347
108. Wolf D, Rodova M, Miska EA, Calvet JP, Kouzarides T. Acetylation of beta-catenin by CREB-binding protein (CBP). J Biol Chem 2002; 277:25562-7; PMID:11973335; http://dx.doi.org/10.1074/jbc.M201196200
109. Song H, Li CW, Labaff AM, Lim SO, Li LY, Kan SF, Chen Y, Zhang K, Lang J, Xie X, et al. Acetylation of EGF receptor contributes to tumor cell resistance to histone deacetylase inhibitors. Biochem Biophys Res Commun 2011; 404:68-73; PMID:21094134; http://dx.doi.org/10.1016/j.bbrc.2010.11.064